XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Statement of Cash Flows [Abstract]    
Net income $ 16,402 $ 12,933
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 4,783 4,942
Provision for credit losses 837 588
Stock-based compensation expense 1,607 1,307
Deferred income tax expense 76 1,514
Amortization of Intangible Assets 318 320
Amortization of debt issuance costs 122 193
Depreciation, Amortization and Accretion, Net 121 100
Net loss on divestitures, disposals and impairment charges 767 21
Gain on insurance reimbursements (1,899) 0
Changes in operating assets and liabilities that provided (used) cash:    
Accounts and preneed receivables (504) (1,521)
Inventories, prepaid and other current assets 2,913 (153)
Intangible and other non-current assets (340) (291)
Preneed funeral and cemetery trust investments (201) (2,952)
Accounts payable (987) (1,712)
Accrued and other liabilities (9,999) 6,853
Deferred preneed funeral and cemetery revenue 628 1,183
Deferred preneed funeral and cemetery receipts held in trust 1,157 3,486
Net cash provided by operating activities 15,801 26,811
Cash flows from investing activities:    
Acquisitions of real estate (2,575) (350)
Proceeds from divestitures and sale of other assets 1,026 2,800
Proceeds from insurance reimbursements 676 0
Capital expenditures (6,883) (4,347)
Net cash used in investing activities (7,756) (1,897)
Cash flows from financing activities:    
Borrowings from the credit facility 70,700 15,168
Payments against the credit facility (51,900) (34,068)
Conversions and maturity of the convertible notes 0 (3,980)
Payments on acquisition debt and obligations under finance leases (100) (233)
Payments on contingent consideration recorded at acquisition date 0 (461)
Proceeds from the exercise of stock options and employee stock purchase plan contributions 663 625
Taxes paid on restricted stock vestings and exercise of stock options (289) (642)
Dividends paid on common stock (1,725) (1,799)
Payments for Repurchase of Common Stock (25,655) 0
Payments of Debt Issuance Costs Credit facility 0 (7)
Net cash used in financing activities (8,306) (25,397)
Net decrease in cash and cash equivalents (261) (483)
Cash and cash equivalents at beginning of period 1,148 889
Cash and cash equivalents at end of period $ 887 $ 406